More theatrical than academic — if both options have a risky short-term outlook, optimize for the story.
Sold for $20B? Or lackluster IPO? As GP of a VC fund, which story is going to better-enable you to raise your next several funds?
More theatrical than academic — if both options have a risky short-term outlook, optimize for the story.
Sold for $20B? Or lackluster IPO? As GP of a VC fund, which story is going to better-enable you to raise your next several funds?